Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Sep. 30, 2024

Restatement of Previously Issued Financial Statements [Abstract]

Schedule of Consolidated Balance Sheets

Summary of Restatements – Consolidated Balance Sheets:

		As of September 30, 2023
		As previously reported				Adjustments				Reference		As restated
ASSETS

CURRENT ASSETS
Cash		$	1,430			$	—					$	1,430
Prepaid expenses			154,519				—						154,519
Advance to a related company			97,882				—						97,882
Deposits			127,664				—						127,664
Other receivables			54,468				—						54,468
Total current assets			435,963				—						435,963

OTHER ASSETS
Property and equipment, net			1,598				—						1,598
Intangible assets, net			5,826,499				(5,826,499	)		a			—
Software, net			337				—						337
Deferred merger costs			—				704,334			b			704,334
Total non-current assets			5,828,434				(5,122,165	)		a, b			706,269

Total assets		$	6,264,397			$	(5,122,165	)		a, b		$	1,142,232

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES
Loans from third parties		$	510,234			$	—					$	510,234
Other payables and accrued expenses			348,807				41,450			c			390,257
Payable to directors			—				2,231,781			d			2,231,781
Total current liabilities			859,041				2,273,231			c, d			3,132,272

OTHER LIABILITIES
Payable to directors			2,231,781				(2,231,781	)		d			—
Compensation payable to a shareholder			5,756,366				(418,093	)		a			5,338,273
Total non-current liabilities			7,988,147				(2,649,874	)		a, d			5,338,273

Total liabilities			8,847,188			$	(376,643	)		a, c, d			8,470,545

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS’ DEFICIT
Ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 137,750,000* shares issued and outstanding as of September 30, 2023			13,775				—						13,775
Additional paid-in capital			587,499				—						587,499
Accumulated deficit			(3,255,885	)			(4,727,705	)		a, b, c			(7,983,590	)
Accumulated other comprehensive income			71,820				(17,817	)		a, b, c			54,003
Total shareholders’ deficit			(2,582,791	)			(4,745,522	)		a, b, c			(7,328,313	)

Total liabilities and shareholders’ deficit		$	6,264,397			$	(5,122,165	)		a, b, c		$	1,142,232

*	Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4.

Schedule of Consolidated Statements of Operations and Comprehensive loss

Summary of Restatements - Consolidated Statements of Operations and Comprehensive loss:

		For the Year Ended September 30, 2023
		As previously reported				Adjustments				Reference		As restated

Operating expenses:
General and administrative expenses		$	2,316,454			$	(1,090,953	)		a, b, c		$	1,225,501
Total operating expenses			2,316,454				(1,090,953	)		a, b, c			1,225,501

Loss from operations			(2,316,454	)			1,090,953			a, b, c			(1,225,501	)

Other income (expenses)
Interest expense, net			(24,207	)			(592,191	)		a			(616,398	)
Total other expense, net			(24,207	)			(592,191	)		a			(616,398	)

Loss before income taxes			(2,340,661	)			498,762			a, b, c			(1,841,899	)

Income tax expense			—				—						—

Net loss		$	(2,340,661	)		$	498,762			a, b, c		$	(1,841,899	)

Foreign currency translation adjustment			68,394				55,604			a, b			123,998

Total comprehensive loss attributable to ordinary shareholders		$	(2,272,267	)		$	554,366			a, b, c		$	(1,717,901	)

Weighted average number of ordinary shares outstanding - basic and diluted*			137,750,000				—						137,750,000

Loss per ordinary share - basic and diluted		$	(0.02	)		$	0.01			a, b, c		$	(0.01	)

*	Giving retroactive effect to reverse recapitalization effected on March 14, 2024 to reflect exchange ratio of approximately 55.1 as described in Note 4.

Schedule of Consolidated Statements of Cash Flows

Summary of Restatements - Consolidated Statements of Cash Flows:

		For the Year Ended September 30, 2023
		As previously reported				Adjustments				Reference		As restated

Cash flows from operating activities:
Net loss		$	(2,340,661	)		$	498,762			a, b, c		$	(1,841,899	)
Adjustments to reconcile net loss to net cash used in operating activities.
Amortization expense			431,593				(431,593	)		a			—
Depreciation expense			103				—						103
Changes in operating assets and liabilities
Prepaid expenses			(77,215	)			—						(77,215	)
Advance to a related company			10,289				—						10,289
Deposits			(127,664	)			—						(127,664	)
Other receivables			(34,183	)			—						(34,183	)
Interests payable			23,380				—						23,380
Other payables and accrued expenses			119,147				41,450			c			160,597
Payable to directors			1,704,724				592,191			a			2,296,915
Net cash provided by operating activities			(290,487	)			700,810			a, b, c			410,323

Cash flows from investing activities:
Purchases of property and equipment			(1,598	)			—						(1,598	)
Net cash used in investing activities			(1,598	)			—						(1,598	)

Cash flows from financing activities:
Payments of deferred merger costs			—				(700,810	)		b			(700,810	)
Net cash used in financing activities			—				(700,810	)		b			(700,810	)

Effect of exchange rate changes			68,394				—						68,394

Net change in cash			(223,691	)			—						(223,691	)

Cash - beginning of the year			225,121				—						225,121

Cash - end of the year		$	1,430			$	—					$	1,430